from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0656c/vapC6

LFCtreatmentdescriptionclass of inhibitor

0.128

Amikacinug/mL Amikacintranslation

0.494

Cap5-10ug/mL Capreomycintranslation

1.157

Rox10-50 ug/mL Roxithromycintranslation

-0.503

SM2-5 ug/mL Streptomycintranslation

0.235

Tet5-10 ug/mL Tetracyclinetranslation

-0.879

Rif0.2-5ug/mL Rifampicintranscription

0.102

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.016

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.073

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.243

CPZ10-50 ug/mL Chlorpromazinerespiration

0.315

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.313

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.852

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.298

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.325

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.533

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.340

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.011

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.015

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.118

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.401

KCN5-20 ug/mL Potassium cyaniderespiration

-1.093

NaN30.2-2 mM Sodium aziderespiration

0.082

Nigericin50 uM Nigericinrespiration

0.217

TRC10-150 ug/mL Triclosanrespiration

-0.332

TRZ10-25 ug/mL Thioridazinerespiration

1.444

Valinomycin0.5-10 uM Valinomycinrespiration

2.518

ZnSO42 mM ZnSO4respiration

-0.031

menadione6-10 ug/mL Menadionerespiration

0.379

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.255

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.012

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.593

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.086

NRP_1Non-replicating persistence stage 1dosRassociated

-0.664

Amp0.2mg/mL AmpicillincellWall

-0.047

Cephalexin20-100 ug/mL CephalexincellWall

-0.014

Cerulenin0.32-5 ug/mL CerulenincellWall

-2.228

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-1.395

EMB10-20 ug/mL EthambutolcellWall

-0.410

Eta12-40 ug/mL EthionamidecellWall

-0.542

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.023

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.601

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.022

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.044

BZA0.12 mg/mL BenzamidearomaticAmides

0.169

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.556

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.823

H2O24 mM hydrogen peroxideDNAdamaging

0.247

Levo10 ug/mL LevofloxacinDNAdamaging

0.187

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.787

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.404

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.048

UVUV-irradiationDNAdamaging

1.730

ARP41-4 ug/mL Antitubercular compound ARP4?

0.246

Antimycin12.5-50 ug/mL Antimycin A?

-0.163

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.462

PA_110-50 ug/mL Antitubercular compound PA-1?

0.385

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.824

PA8240.2-2 ug/mL PA-824?

0.800

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.537

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.144

Verapamil50 uM Verapamil?

-0.123

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.180

methoxatin10-20 ug/mL Methoxatin?